Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study
Objective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patient...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2022-04-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | https://www.cancerbiomed.org/content/19/4/551 |
_version_ | 1811244996389502976 |
---|---|
author | Hui Lu Shanshan Guo Liting Liu Qiuyan Chen Yujing Liang Sailan Liu Xuesong Sun Qingnan Tang Xiaoyun Li Ling Guo Haoyuan Mo Linquan Tang Haiqiang Mai |
author_facet | Hui Lu Shanshan Guo Liting Liu Qiuyan Chen Yujing Liang Sailan Liu Xuesong Sun Qingnan Tang Xiaoyun Li Ling Guo Haoyuan Mo Linquan Tang Haiqiang Mai |
author_sort | Hui Lu |
collection | DOAJ |
description | Objective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patients with advanced nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed 433 patients with advanced NPC having no evidence of metastasis from January 2007 to June 2011; the patients underwent radical concurrent chemoradiotherapy (CCRT) at Sun Yat-sen University Cancer Center and were grouped based on their ΔCONUT and ΔCONUT-EBV DNA scores. Kaplan-Meier curves were used to compare the patient outcomes according to the cut-off ΔCONUT score and the ΔCONUT-EBV DNA scoring system. Results: Among all patients, overall survival (OS) was independently predicted by a high ΔCONUT score (P = 0.031) and high EBV DNA (P < 0.001). The ΔCONUT-EBV DNA score [OS area under the curve (AUC) = 0.621; progression free survival (PFS)-AUC = 0.612; distant metastasis-free survival (DMFS)-AUC = 0.622] was more predictive of OS, PFS, and DMFS in patients with advanced NPC than the ΔCONUT score (OS-AUC = 0.547; PFS-AUC = 0.533; DMFS-AUC = 0.522) and pretreatment plasma EBV DNA levels alone (OS-AUC = 0.600; PFS-AUC = 0.591, DMFS-AUC = 0.610). The ΔCONUT-EBV DNA score was significantly correlated with OS, PFS, and DMFS in patients with advanced NPC treated with CCRT. Conclusions: The ΔCONUT-EBV DNA score may be useful in clinical practice as a convenient biomarker for predicting the outcomes in patients with advanced NPC treated with CCRT. |
first_indexed | 2024-04-12T14:33:28Z |
format | Article |
id | doaj.art-a014f4cdf0b04744a95c7e19f0b3e457 |
institution | Directory Open Access Journal |
issn | 2095-3941 |
language | English |
last_indexed | 2024-04-12T14:33:28Z |
publishDate | 2022-04-01 |
publisher | China Anti-Cancer Association |
record_format | Article |
series | Cancer Biology & Medicine |
spelling | doaj.art-a014f4cdf0b04744a95c7e19f0b3e4572022-12-22T03:29:10ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412022-04-0119455156410.20892/j.issn.2095-3941.2020.0627Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up studyHui Lu0Shanshan Guo1Liting Liu2Qiuyan Chen3Yujing Liang4Sailan Liu5Xuesong Sun6Qingnan Tang7Xiaoyun Li8Ling Guo9Haoyuan Mo10Linquan Tang11Haiqiang Mai12State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaState Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, ChinaObjective: Several studies have reported that the controlling nutritional status (CONUT) score is a prognostic predictor for survival among patients with different types of cancer. We assessed the prognostic value of changes in the CONUT score during treatment and the ΔCONUT-EBV DNA score in patients with advanced nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed 433 patients with advanced NPC having no evidence of metastasis from January 2007 to June 2011; the patients underwent radical concurrent chemoradiotherapy (CCRT) at Sun Yat-sen University Cancer Center and were grouped based on their ΔCONUT and ΔCONUT-EBV DNA scores. Kaplan-Meier curves were used to compare the patient outcomes according to the cut-off ΔCONUT score and the ΔCONUT-EBV DNA scoring system. Results: Among all patients, overall survival (OS) was independently predicted by a high ΔCONUT score (P = 0.031) and high EBV DNA (P < 0.001). The ΔCONUT-EBV DNA score [OS area under the curve (AUC) = 0.621; progression free survival (PFS)-AUC = 0.612; distant metastasis-free survival (DMFS)-AUC = 0.622] was more predictive of OS, PFS, and DMFS in patients with advanced NPC than the ΔCONUT score (OS-AUC = 0.547; PFS-AUC = 0.533; DMFS-AUC = 0.522) and pretreatment plasma EBV DNA levels alone (OS-AUC = 0.600; PFS-AUC = 0.591, DMFS-AUC = 0.610). The ΔCONUT-EBV DNA score was significantly correlated with OS, PFS, and DMFS in patients with advanced NPC treated with CCRT. Conclusions: The ΔCONUT-EBV DNA score may be useful in clinical practice as a convenient biomarker for predicting the outcomes in patients with advanced NPC treated with CCRT.https://www.cancerbiomed.org/content/19/4/551controlling nutritional status scoreepstein-barr virus deoxyribonucleic acidnasopharyngeal carcinomaprognosispredictive factor |
spellingShingle | Hui Lu Shanshan Guo Liting Liu Qiuyan Chen Yujing Liang Sailan Liu Xuesong Sun Qingnan Tang Xiaoyun Li Ling Guo Haoyuan Mo Linquan Tang Haiqiang Mai Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study Cancer Biology & Medicine controlling nutritional status score epstein-barr virus deoxyribonucleic acid nasopharyngeal carcinoma prognosis predictive factor |
title | Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study |
title_full | Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study |
title_fullStr | Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study |
title_full_unstemmed | Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study |
title_short | Prognostic significance of a combined and controlled nutritional status score and EBV-DNA in patients with advanced nasopharyngeal carcinoma: a long-term follow-up study |
title_sort | prognostic significance of a combined and controlled nutritional status score and ebv dna in patients with advanced nasopharyngeal carcinoma a long term follow up study |
topic | controlling nutritional status score epstein-barr virus deoxyribonucleic acid nasopharyngeal carcinoma prognosis predictive factor |
url | https://www.cancerbiomed.org/content/19/4/551 |
work_keys_str_mv | AT huilu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT shanshanguo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT litingliu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT qiuyanchen prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT yujingliang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT sailanliu prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT xuesongsun prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT qingnantang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT xiaoyunli prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT lingguo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT haoyuanmo prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT linquantang prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy AT haiqiangmai prognosticsignificanceofacombinedandcontrollednutritionalstatusscoreandebvdnainpatientswithadvancednasopharyngealcarcinomaalongtermfollowupstudy |